Literature DB >> 5645849

The pattern of genetic transmission of the leukocyte defect in fatal granulomatous disease of childhood.

D B Windhorst, A R Page, B Holmes, P G Quie, R A Good.   

Abstract

The leukocyte-phagocytic function test which was found to be abnormal in boys with fatal granulomatous disease of childhood has been found to be abnormal to an intermediate extent in their mothers. Nine of nine mothers were shown to be abnormal, whereas none of eight fathers and none of five healthy brothers exhibited a defect. 10 of 16 female siblings were abnormal to the same degree as their mothers, as were all three maternal grandmothers available for study. Assuming that this intermediate functional defect represents the heterozygous state, the nine family pedigrees are entirely compatible with the concept that the trait is transmitted on the X-chromosome.A tetrazolium dye-phagocytosis histochemical test was also abnormal in the carrier females and provided independent confirmation of the selection of the female siblings suspected of being carriers for the trait. In addition, this procedure gives indirect evidence that the gene in question is subject to the random inactivation that appears to affect many X-linked genes in mammalian females. The family members were also studied with two of the metabolic assays that have been shown to be abnormal in the cells of affected boys. One assay, the oxidation of the first carbon of glucose-1-(14)C by the isolated leukocytes, was significantly abnormal in the cells of carrier females. The other assay, the oxidation of formate-(14)C by leukocytes of heterozygotes was not significantly different from control values. The practical problem of diagnosing patients would appear to be best solved with a tetrazolium dye procedure, whereas the more subtle abnormality in carrier females is best detected with the leukocyte function test. Improved methods for the function test are being developed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645849      PMCID: PMC297255          DOI: 10.1172/JCI105792

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.

Authors:  R A BRIDGES; H BERENDES; R A GOOD
Journal:  AMA J Dis Child       Date:  1959-04

2.  A fatal granulomatosus of childhood: the clinical study of a new syndrome.

Authors:  H BERENDES; R A BRIDGES; R A GOOD
Journal:  Minn Med       Date:  1957-05

3.  Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function.

Authors:  B Holmes; P G Quie; D B Windhorst; R A Good
Journal:  Lancet       Date:  1966-06-04       Impact factor: 79.321

4.  Fatal granulomatous disease of childhood.

Authors:  A Jansz; J Huber
Journal:  Lancet       Date:  1967-04-15       Impact factor: 79.321

5.  A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females.

Authors:  D B Windhorst; B Holmes; R A Good
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

6.  Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis).

Authors:  P S Macfarlane; A L Speirs; R G Sommerville
Journal:  Lancet       Date:  1967-02-25       Impact factor: 79.321

7.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

8.  Protection of phagocytized bacteria from the killing action of antibiotics.

Authors:  B Holmes; P G Quie; D B Windhorst; B Pollara; R A Good
Journal:  Nature       Date:  1966-06-11       Impact factor: 49.962

9.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  Gene action in the X-chromosome of the mouse (Mus musculus L.).

Authors:  M F LYON
Journal:  Nature       Date:  1961-04-22       Impact factor: 49.962

View more
  19 in total

1.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

2.  Successful bone marrow transplantation in a patient with humoral and cellular immunity deficiency.

Authors:  A J Ammann; H J Meuwissen; R A Good; R Hong
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

3.  Chronic granulomatous disease: quantitative clinicopathological relationships.

Authors:  E N Thompson; J F Soothill
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

Review 4.  The role of phagocyte function in resistance to infection.

Authors:  R I Lehrer
Journal:  Calif Med       Date:  1971-06

Review 5.  Genetics of immunity deficiency syndromes.

Authors:  H E Kay
Journal:  J Med Genet       Date:  1970-12       Impact factor: 6.318

Review 6.  [Immunologic function of monocytes and macrophages].

Authors:  H Huber; H H Fudenberg
Journal:  Klin Wochenschr       Date:  1969-10-15

7.  Canine granulocytopathy syndrome: an inherited disorder of leukocyte function.

Authors:  H W Renshaw; W C Davis
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

8.  Reduced germination of Clostridium botulinum type A spores in vitro by polymorphonuclear leukocytes from chronic granulomatous disease.

Authors:  J B Suzuki; N Grecz; D Windhorst
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

9.  X-linked inheritance in females with chronic granulomatous disease.

Authors:  E L Mills; K S Rholl; P G Quie
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease.

Authors:  K Kragballe; N Borregaard; F Brandrup; C Koch; K Staehrjohansen
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.